Using overexpression of laminin alpha 4 subunit as a diagnostic and prognostic indicator of malignant tumors

Details for Australian Patent Application No. 2002246833 (hide)

Owner CEDARS-SINAI MEDICAL CENTER

Inventors Ljubimov, Alexander, V.; Black, Keith, L.; Ljubimova, Julia, Y.

Agent Cullens

Pub. Number AU-A-2002246833

PCT Pub. Number WO2002/059610

Priority 09/741,550 19.12.00 US

Filing date 19 December 2001

Wipo publication date 6 August 2002

International Classifications

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002246833

15 January 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Cedars-Sinai Medical Center to Arrogene, Inc.

28 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246834-FGFRL1 GENE AND PROTEIN ENCODED THEREBY

2002246832-DETECTION OF TRACE LEVELS OF WATER